Form 10-Q Barings BDC, Inc. For: Jun 30
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260805/AFZ2B22CZ22DK2Z2222I22ZMGVMAAZ2S5282
Filed on: August 5, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KBW Announces Index Rebalancing for Third-Quarter 2026
- You May Be Entitled to a Cash Payment From a Class Action Settlement if You Performed a Skin360® Skin Assessment Using Any Version of Skin360®, Including Neutrogena® Skin360®, NeoStrata® Skin360�
- FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
